Onglyza is a DPP-4 class inhibitor prescribed to those that suffer from type 2 diabetes. It works to promote healthy blood-sugar levels as well as insulin regulation. It has grown in popularity due to it lacking a common side effect of weight gain that most drugs of this type are associated with. Lawsuits are currently […]
Our Onglyza lawsuit attorneys are investigating lawsuits for wrongful death cases against the drug manufacturer. FDA reports and independent studies have shown that Onglyza increases the risk of pancreatic cancer. Pancreatic cancer, being the deadliest form of cancer due to its difficulty in early detection is extremely dangerous and can often lead to death. If […]
Onglyza lawsuits are currently being investigated against AstraZeneca for complications including heightening the risk of pancreatic cancer. Settlements have yet to be determined and most lawsuits are still being investigated, however, those that have suffered due to this drug may be eligible to begin investigating a claim. If you believe that you or a loved one […]
If you or a loved one believes to have suffered a heightened risk of pancreatic cancer due to their prescription to Onglyza, you should contact one of our dangerous drug attorneys today. If it is determined that they suffered as a result of the drug, you may be eligible to sue the drug manufacturer. Several […]
Patients who have suffered complications arising from the use of Onglyza have legal rights to compensation. Lawsuits are currently being investigated throughout the United State against the drug manufacturer who created and sold the medication. There are specific deadlines for filing dangerous drug cases. These deadlines, referred to as “statute of limitations” vary from state […]
Our Onglyza lawsuit attorneys are an excellent choice to handle your Onglyza drug lawsuit. We have the experience, skill, and resources that you need on your side to handle and win your claim against the drug manufacturers. We have been named Super Lawyers and currently hold a perfect 10 rating on AVVO as well as […]
One of the most dangerous complications stemming from Onglyza is the heightened risk of developing pancreatic cancer. Pancreatic cancer is one of the deadliest cancers with a five year survival rate of only 6%. This is because of the difficulty in discovering it before it has spread to other parts of the body, making eradication […]
The most serious complication associated with Onglyza is the heightened risk of developing pancreatic cancer. Pancreatic cancer, being the most volatile of cancers is nearly undetectable in early stages and is often only detected once it has spread to other parts of the body. In 2013 the FDA issued a safety communication acknowledging the correlation […]
To find out if you are eligible to file a potential Onglyza lawsuit, you should contact us so we can begin researching your case. There are set criteria factors that determine if you have the ability to file an individual or class action lawsuit against the makers of the drug. The criteria includes when you […]
A major complication reportedly linked to Onglyza is heart attacks and other heart-related issues, including heart failure. Onglyza (saxagliptin) is a type 2 diabetes medication that was approved by the FDA on July 31, 2009. The drug is used to help control blood sugar in type 2 diabetes patients who do not suffer from diabetic ketoacidosis […]